Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/32899
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZannettino, A.-
dc.contributor.authorPan, B.-
dc.contributor.authorFarrugia, A.-
dc.contributor.authorAtkins, G.-
dc.contributor.authorTo, L.-
dc.date.issued2004-
dc.identifier.citationCancer Research, 2004; 64(2):774-775-
dc.identifier.issn0008-5472-
dc.identifier.urihttp://hdl.handle.net/2440/32899-
dc.description© 2004 American Association for Cancer Research-
dc.description.statementofresponsibilityAndrew C. W. Zannettino, Beiqing Pan, Amanda N. Farrugia, Gerald J. Atkins and L. Bik To-
dc.language.isoen-
dc.publisherAmer Assoc Cancer Research-
dc.source.urihttp://cancerres.aacrjournals.org/cgi/content/full/64/2/773-
dc.titleIdentification and clinical relevance of receptor activator of nuclear factor kappa B ligand expression of myeloma cells - Reply-
dc.typeJournal article-
pubs.publication-statusPublished-
dc.identifier.orcidZannettino, A. [0000-0002-6646-6167]-
dc.identifier.orcidAtkins, G. [0000-0002-3123-9861]-
Appears in Collections:Aurora harvest
Orthopaedics and Trauma publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.